These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19415462)

  • 1. Altered gene and protein expression by Nm23-H1 in metastasis suppression.
    Lee JH; Marshall JC; Steeg PS; Horak CE
    Mol Cell Biochem; 2009 Sep; 329(1-2):141-8. PubMed ID: 19415462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2.
    Horak CE; Mendoza A; Vega-Valle E; Albaugh M; Graff-Cherry C; McDermott WG; Hua E; Merino MJ; Steinberg SM; Khanna C; Steeg PS
    Cancer Res; 2007 Dec; 67(24):11751-9. PubMed ID: 18089805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulators affecting the metastasis suppressor activity of Nm23-H1.
    Kim HD; Youn B; Kim TS; Kim SH; Shin HS; Kim J
    Mol Cell Biochem; 2009 Sep; 329(1-2):167-73. PubMed ID: 19377884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The multiple regulation of metastasis suppressor NM23-H1 in cancer.
    Yu L; Wang X; Zhang W; Khan E; Lin C; Guo C
    Life Sci; 2021 Mar; 268():118995. PubMed ID: 33421524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.
    Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS
    Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Function of NM23-H1/NME1 and Its Homologs in Major Processes Linked to Metastasis.
    Mátyási B; Farkas Z; Kopper L; Sebestyén A; Boissan M; Mehta A; Takács-Vellai K
    Pathol Oncol Res; 2020 Jan; 26(1):49-61. PubMed ID: 31993913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in Gemin5 expression contribute to alternative mRNA splicing patterns and tumor cell motility.
    Lee JH; Horak CE; Khanna C; Meng Z; Yu LR; Veenstra TD; Steeg PS
    Cancer Res; 2008 Feb; 68(3):639-44. PubMed ID: 18245461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting tumor metastasis by regulating Nm23 gene expression.
    Prabhu VV; Siddikuzzaman ; Grace VM; Guruvayoorappan C
    Asian Pac J Cancer Prev; 2012; 13(8):3539-48. PubMed ID: 23098432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of N-acetylglucosaminyltransferase V by tumorigenesis- or metastasis-suppressor gene and its relation to metastatic potential of human hepatocarcinoma cells.
    Guo HB; Liu F; Zhao JH; Chen HL
    J Cell Biochem; 2000 Sep; 79(3):370-85. PubMed ID: 10972975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential contributions of antimutator activity to the metastasis suppressor function of NM23-H1.
    Kaetzel DM; McCorkle JR; Novak M; Yang M; Jarrett SG
    Mol Cell Biochem; 2009 Sep; 329(1-2):161-5. PubMed ID: 19381784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Abl and Arg induce cathepsin-mediated lysosomal degradation of the NM23-H1 metastasis suppressor in invasive cancer.
    Fiore LS; Ganguly SS; Sledziona J; Cibull ML; Wang C; Richards DL; Neltner JM; Beach C; McCorkle JR; Kaetzel DM; Plattner R
    Oncogene; 2014 Sep; 33(36):4508-4520. PubMed ID: 24096484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition.
    Hartsough MT; Clare SE; Mair M; Elkahloun AG; Sgroi D; Osborne CK; Clark G; Steeg PS
    Cancer Res; 2001 Mar; 61(5):2320-7. PubMed ID: 11280805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration in gene expression profile and biological behavior in human lung cancer cell line NL9980 by nm23-H1 gene silencing.
    Ma W; Chen J; Xue X; Wang Z; Liu H; Wang T; Bai Y; Tang SC; Zhou Q
    Biochem Biophys Res Commun; 2008 Jul; 371(3):425-30. PubMed ID: 18440302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations at the dimer interface and surface residues of Nm23-H1 metastasis suppressor affect its expression and function.
    Li Y; Liu W; Saini V; Wong YH
    Mol Cell Biochem; 2020 Nov; 474(1-2):95-112. PubMed ID: 32705629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [NM23, an example of a metastasis suppressor gene].
    Boissan M; Lacombe ML
    Bull Cancer; 2012 Apr; 99(4):431-40. PubMed ID: 22429909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Nm23-H1-h-Prune complex in cellular physiology: a 'tip of the iceberg' protein network perspective.
    Galasso A; Zollo M
    Mol Cell Biochem; 2009 Sep; 329(1-2):149-59. PubMed ID: 19390954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical-translational approaches to the Nm23-H1 metastasis suppressor.
    Steeg PS; Horak CE; Miller KD
    Clin Cancer Res; 2008 Aug; 14(16):5006-12. PubMed ID: 18698018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nm23-H1 inhibits lung cancer bone-specific metastasis by upregulating miR-660-5p targeted SMARCA5.
    Ai C; Ma G; Deng Y; Zheng Q; Gen Y; Li W; Li Y; Zu L; Zhou Q
    Thorac Cancer; 2020 Mar; 11(3):640-650. PubMed ID: 32022430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nm23-h1 binds to gelsolin and inactivates its actin-severing capacity to promote tumor cell motility and metastasis.
    Marino N; Marshall JC; Collins JW; Zhou M; Qian Y; Veenstra T; Steeg PS
    Cancer Res; 2013 Oct; 73(19):5949-62. PubMed ID: 23940300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of nm23-H1 as a metastatic suppressor and prognostic factor in nasopharyngeal carcinoma by proteomic analysis.
    Li X; Hu R; Qu J; He Q; Chen Y; Li J; Ye X; Xiang Y; Yi H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 37(1):17-26. PubMed ID: 22349375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.